Change in BMI ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement of other clinical signs of hyperandrogenism ‐ not measured · women with hirsutism
1 finding from 1 review
Total number of oral ulcers · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
Colchicine (systemic; 0.5 mg weight-adjusted daily) showed no clear difference in total number of oral ulcers compared with placebo (moderate certainty).
1 finding from 1 review
Mean number of oral ulcers · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Melikoglu 2005 (etanercept 25 mg s.c. twice weekly for 4 weeks vs placebo, 40 male patients; high risk of reporting bias): authors reported a statistically significant difference in mean number of oral ulcers with…
1 study · 40 participants
GRADE not reported
Parasitological failure At 2 to 2.5 months · patients with treating urinary schistosomiasis
Metrifonate 3 x 7.5 mg/kg given two weeks apart may leads to lower parasitological failure At 2 to 2.5 months compared with placebo (low certainty).
1 finding from 1 review
Mean percent egg reduction At 2 to 2.5 months · patients with treating urinary schistosomiasis
1 finding from 1 review
Parasitological failure At 6 months · patients with treating urinary schistosomiasis
Metrifonate 3 x 7.5 mg/kg given two weeks apart probably leads to lower parasitological failure At 6 months compared with placebo (moderate certainty).
1 finding from 1 review
Mean percent egg reduction At 6 months · patients with treating urinary schistosomiasis
1 finding from 1 review
Adverse events · patients with treating urinary schistosomiasis
1 finding from 1 review
Complete suppression of urticaria: intermediate‐term duration of intervention (levocetirizine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Withdrawals due to adverse events · patients with chronic spontaneous urticaria
Hydroxyzine 25 mg showed no clear difference in adverse events leading to withdrawal: intermediate‐term duration of… compared with placebo (low certainty).
1 finding from 1 review
Complete suppression of urticaria: short‐term duration of intervention (desloratadine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Complete suppression of urticaria: intermediate‐term duration of intervention (desloratadine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Adverse effects requiring withdrawal/discontinuation of study medication · patients with chronic spontaneous urticaria
Desloratadine 5 to 20 mg showed no clear difference in adverse effects leading to withdrawal: intermediate‐term duration of… compared with placebo (low certainty).
1 finding from 1 review
Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria
1 finding from 1 review
Maintenance of clinical remission · Participants with Crohn's disease in remission
Methotrexate probably leads to higher proportion of patients maintaining clinical remission (high dose… compared with placebo (moderate certainty).
2 findings from 1 review
Antiviral response ‐ 0.5mg/Kg · patients being treated for HIV infection
It is very uncertain whether PRO 140 changes antiviral response: 0.5 mg/kg compared with placebo (very low certainty).
1 finding from 1 review
Individual nadir changes in HIV‐1 RNA level ‐ 5mg/Kg · patients being treated for HIV infection
1 finding from 1 review
Antiviral response ‐ 5mg/Kg · patients being treated for HIV infection
It is very uncertain whether PRO 140 changes antiviral response: 5 mg/kg compared with placebo (very low certainty).
1 finding from 1 review
Individual nadir changes in HIV‐1 RNA level ‐ 0.5mg/Kg · patients being treated for HIV infection
1 finding from 1 review